Hiloprobe is a research-based company in the cancer diagnostic field. Hiloprobe is developing ColoNode® – a biomarker test for the accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients.
Hiloprobe joined NOME in 2022 and is headed by Lina Olsson.